Microtubule destabilizers, such as these, potentially alter HLA expression by upregulating the production of cytokines (IFNα, IL-1β, IL-6, IL-12) involved in HLA expression or disrupt intracellular trafficking of HLA proteins, causing redistribution at the tumor surface [49,50]. The gene discussed is IL1B; the disease is neoplasm.